Theranos has settled its lawsuits with a hedge fund that invested $96.1 million in the company. Partner Fund Management originally sued Theranos in October 2016, alleging the company had "engaged in securities fraud and other violations." And in April, court filings reported by The Wall Street Journal alleged that Theranos used a shell company to purchase commercially available lab equipment and faked blood tests in presentations with prospective investors and business partners.